Atlas Venture related stories
All articles and analysis
Deal round-up 21/03/03Granville Baird backs Amann Druckguss growth; Nomura backs $46m healthcare round; GIMV, Big Bang lead ORMvision round; German pharma company lands E30m series C financing; Banexi joins La Toulousaine MBO
- Accel cuts fund VIII again
The firm has reduced its eighth fund by 29 per cent to $680m, less than half the original $1.4bn raised in 2000.
- US firms continue VC cutbacks
Texas-based Sevin Rosen Funds has become the latest US venture capital firm to cut its fund back, from $875m to $600m.
- Deal round-up 25/02/02
Phoenix continues Covenant expansion; Three exits for 3i; First deal for Albany’s third fund; Atlas Venture leads Arteris first round; Bridgepoint backs Hydrex buy-and-build.
- US VC fundraising falls to ten-year low
US venture capital fundraising fell by over 80 per cent to $6.9bn in 2002, while existing VC funds were downsized by around $5bn.
- Mohr Davidow continues cutback trend
The US-based firm has become the third venture capital firm to make a second cutback on earlier fundraising, cutting a further $200m from its seventh fund.
- Mobius returns $250M from Fund VI
The Japanese venture firm has announced the second cutback from one of its VC funds, the fifteenth reduction of its kind since the beginning of 2002.
- Deal round-up 31/01/03
UK VCs back UDEX; Super Dimension lands $13m third round; Renovo adds to second round financing; Novartis, Nextech back Genetics acquisition; Novartis, Nextech back Genetics acquisition; Private Equity Investor exits Okena; AXA PE takes Planisware minority stake
- Benchmark backs tech PTP
In a change from its established strategy of investing in start-up and early stage companies, Benchmark Capital is to finance an E80m public-to-private deal for electronic transactions company Alphyra.